Position in LKFT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$39,572
+$35,072 QoQ
Shares Held
1,320
+780.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 78 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,919,879,903 across 425 Biotechnology names. LKFT ranks #313 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in LKFT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,572 | 1,320 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,500 | 150 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,814 | 239 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,459 | 71 | Shares | Defined | 2025-11-07 | |
| 2025-03-31 | $20,975 | 835 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $28,902 | 1,051 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $62,963 | 2,187 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $56,523 | 2,281 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $141,712 | 4,401 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $243 | 6 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $126,522 | 3,662 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $20,817 | 512 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $19,281 | 499 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $20,592 | 464 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $40,976 | 961 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,429,137 | 294,429 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $18,588,012 | 299,710 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $16,124,807 | 292,487 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $15,376,165 | 292,267 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $30,861 | 448 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $2,621 | 34 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,245 | 53 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $2,269 | 16 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $107,916 | 547 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $5,260,255 | 26,849 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||